Vulnerability in Roche Accu-Chek Inform Ii
CVE-2018-18564
An issue was discovered in Roche Accu-Chek Inform II Instrument before 03.06.00 (Serial number below 14000) and 04.x before 04.03.00 (Serial Number above 14000), CoaguChek Pro II before 04.03.00, and cobas h 232 before 04.00.04 (Serial number above KQ0400000 or KS0400000). Improper access control allows attackers in the adjacent network to change the instrument configuration.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.4 (High). Vector: CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:C/C:N/I:H/A:N.
EPSS exploit prediction
EPSS: 0.006 (45.9th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 46th percentile — 45.9% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.006 · newest: 0.006 · change: 0.000
Affected products
References
- ics-cert.us-cert.gov/advisories/ICSMA-18-310-01 (US Government Resource, Third Party Advisory, Mitigation)
- www.securityfocus.com/bid/105843 (VDB Entry, Third Party Advisory, vdb-entry)
Frequently asked questions
- What is CVE-2018-18564?
- CVE-2018-18564 is a high-severity vulnerability in Roche Accu-Chek Inform Ii. CVSS score: 7.4/10. Published 2018-11-20.
- How severe is CVE-2018-18564?
- High severity. CVSS v3 base score is 7.4 out of 10.